IMARC Group’s latest research report, titled “In-vitro Colorectal Cancer Screening Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the global In-vitro colorectal cancer screening tests market size. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global in-vitro colorectal cancer screening tests market reached a value of US$ 880.1 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1,284.90 Million by 2027, exhibiting a CAGR of 6.10% during 2022-2027. In-vitro colorectal cancer screening tests are used to detect the presence of colorectal cancer. Colorectal cancer is of two types, namely bowel and colon cancer, which starts with a foreign growth on the inner lining of the colon or rectum. It includes a fecal occult blood test, biomarker tests, and CRC DNA screening tests. These tests are performed across hospitals, clinics, diagnostics laboratories, and ambulatory surgical centers.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/in-vitro-colorectal-cancer-screening-tests-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by product, imaging type and end user.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for In-vitro Colorectal Cancer Screening Tests Market
- Strategies of major players and product offerings
The global market is primarily driven by the rising prevalence of colorectal cancer. In line with this, the augmenting utilization of in-vitro colorectal cancer screening tests for diagnosing recurrence after therapy and surgery is favorably influencing the market. Furthermore, the growing awareness among the masses regarding the high-accuracy rates of in-vitro colorectal cancer screening tests is creating a positive outlook for the market. Additionally, continual technological advancements for cancer screening and the rapid expansion of screening activities are providing a boost to market growth across the globe.
Key Players Included in Global In-vitro Colorectal Cancer Screening Tests Market Research Report:
- Beckman Coulter Inc. (Danaher Corporation)
- Eiken Chemical Co. Ltd.
- Epigenomics AG
- Exact Sciences Corporation
- Hemosure Inc.
- Immunostics Inc. (Boditech Med Inc.)
- Medline Industries LP
- Merck KGaA, Qiagen N.V.
- Quest Diagnostics Incorporated
- R-Biopharm AG
- Siemens AG and Sysmex Corporation
COVID-19 Impact Overview:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report
Key Market Segmentation:
Breakup by Product:
Fecal Occult Blood Tests
- Guaiac FOB Stool Test
- Immuno-FOB Agglutination Test
- Lateral Flow Immuno-FOB Test
- Immuno-FOB ELISA Test
- Tumor M2-PK Stool Test
- Transferrin Assays
CRC DNA Screening Tests
- Methylated Gene Testing
- Panel DNA Tests
Breakup by Imaging Type:
- CT Scan
- PET Scan
Breakup by End User:
- Diagnostic Laboratories
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
TOC for the In-vitro Colorectal Cancer Screening Tests Market Research Report:
- Scope and Methodology
- Executive Summary
- Global In-vitro Colorectal Cancer Screening Tests Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800